10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839
Thursday 5 Nov642 filings read · 590 material
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
United Parks & Resorts Inc.PRKS
8-K · Item 2.02 — Results of operations
Q3 2026 attendance declined 4.7% YoY to 6.5M guests; total revenue fell 1.1% to $506.5M; net income dropped 10.5% to $80.0M; Adjusted EBITDA decreased 5.1% to $205.1M. Nine-month net income fell 28.8% YoY despite modest revenue decline.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
DNOW Inc.DNOW
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $1,337M nearly doubled YoY; adjusted EBITDA of $76M nearly doubled Q1 results. Strong cash generation ($120M operating cash flow), improved leverage (1.1x net debt), and broad-based growth across segments.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
ARKO Corp.ARKO
8-K · Item 2.02 — Results of operations
ARKO raised FY2026 Adjusted EBITDA guidance to $250–265M (vs. prior range), reported Q3 net income of $14.3M, achieved 12 consecutive quarters of merchandise margin expansion (34.8%), and announced subsidiary APC's $205M acquisition of USPP fuel business expected to add ~280M gallons annually and ~$30M Adjusted EBITDA.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
ARKO Corp.ARKO
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Biotech
Amylyx Pharmaceuticals, Inc.AMLX
8-K · Item 2.02 — Results of operations
Amylyx reported positive Phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia, meeting primary endpoint with 55% reduction in hypoglycemic events (p=0.000003). NDA submission planned by end-2026. Company raised ~$545M, strengthening balance sheet to $768M.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Biotech
Monte Rosa Therapeutics, Inc.GLUE
8-K · Item 2.02 — Results of operations
Monte Rosa reported positive Phase 1 results for MRT-8102 showing substantial reduction in inflammatory markers comparable to healthy volunteers with favorable safety. Multiple Phase 2 initiations planned across gout, CAD, and hidradenitis suppurativa. Novartis triggered $87.5M in milestone payments for MRT-6160 Phase 2 studies.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Nexstar reported record Q3 2026 net revenue of $2.1B (+78% YoY), net income of $250M (+285% YoY), and Adjusted EBITDA of $756M (+111% YoY), driven by TEGNA acquisition and record political advertising revenue of $317M.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Biotech
REGENXBIO Inc.RGNX
8-K · Item 2.02 — Results of operations
REGENXBIO reported Q3 2026 results with key pipeline milestones: RGX-202 BLA submission on track for Q1 2027 with potential 2H 2027 approval; pivotal wet AMD trial data expected Q4 2026. Cash position strengthened to $251M plus $39M settlement. Revenue declined due to ZOLGENSMA patent expiration, offset by new ITVISMA royalties.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
Wendy's CoWEN
8-K · Items 1.01, 3.03, 5.02 — Material agreement
Wendy's Board adopted a stockholder rights plan on November 4, 2026, in response to an unsolicited $7.35/share acquisition proposal from Trian Fund Management and partners. The plan imposes significant dilution on any person acquiring 15%+ of shares without Board approval, effectively making hostile takeover more difficult.
The filings read less positively.
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
The gap narrowed as the filings read less positively.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026: Revenue grew 106% YoY to $624M; diluted EPS $1.28 vs $1.11 prior year; adjusted EPS $1.44 vs $1.15; combined ratio 61%; mortgage insurance in force reached record $286B; specialty segment contributed 57% of net premiums.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Biotech
Intellia Therapeutics, Inc.NTLA
8-K · Item 2.02 — Results of operations
FDA accepted lonvo-z BLA with Priority Review (PDUFA March 10, 2027); completed MAGNITUDE-2 enrollment; secured $400M term loan. Company on track for Q1 2027 commercial launch of first in vivo CRISPR therapy for HAE.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Loar reported Q3 2026 record results with net sales up 39% YoY to $176.2M and Adjusted EBITDA up 46.5% to $71.9M. Company raised full-year 2026 and issued 2027 guidance, citing strong order backlog and demand across commercial OEM, aftermarket, and defense end markets.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Victory Capital Holdings, Inc.VCTR
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
DNOW Inc.DNOW
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Software / SaaS
Cars.com Inc.CARS
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Janux reported Q3 2026 results with improved net loss ($21.6M vs $24.3M YoY), strong cash position ($945.7M), and multiple clinical milestones including first patient dosed in JANX013 combination study and upcoming JANX011 data presentation.
Market attention has faded.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Sana reported Q3 2026 results with continued progress toward SC451 Phase 1/2 trial initiation and SG293 clinical study launch. UP421 showed 14-month durability in NEJM publication. Cash position $121.7M with runway into mid-2027. Non-GAAP net loss improved year-over-year.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend strengthened.
10-QFiled 5 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Priority Technology Holdings, Inc.PRTH
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026Software / SaaS
Red Violet, Inc.RDVT
8-K · Item 2.02 — Results of operations
Red Violet reported Q3 2026 revenue of $27.8M (+20% YoY), surpassing $100M trailing twelve-month revenue for the first time. Net income grew 29% to $5.4M; operating cash flow increased 25% to $12.7M. Company raised $108.7M in capital via public offering.
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Q3 2026 record sales of $230M (+4% YoY, +13% pro-forma), diluted EPS $0.53 (+71%), adjusted EPS $0.80 (+11%). Raised FY2026 sales outlook to $895–$902M (highest in company history). Record operating cash flow $40M (+59%).
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026Semiconductors
Diodes Inc /Del/DIOD
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Frontdoor, Inc.FTDR
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Banks
8-K · Item 2.02 — Results of operations
The gap narrowed as the filings read less positively.
The price trend strengthened.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Banks
8-K · Item 2.02 — Results of operations
Q3 2026 revenue declined 59% YoY to $28M due to deliberate Bitcoin mining cessation. Net loss of $63M driven by $55M non-cash derivative loss. Company maintains $780M liquidity but faces execution risks on HPC infrastructure pivot and lease negotiations.
The gap narrowed as the filings read less positively.
10-QFiled 5 Nov 2026Biotech
Rezolute, Inc.RZLT
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Core Scientific reported Q3 2026 colocation revenue of $215.4M, up 57% sequentially, with 485 MW billing capacity and $700M+ annualized revenue run-rate. Adjusted EBITDA tripled to $133.6M with 57% margins. Strong execution on contracted capacity delivery.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
APA CorpAPA
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026Software / SaaS
Consensus Cloud Solutions, Inc.CCSI
8-K · Item 2.02 — Results of operations
Q3 2026 revenues grew 3.7% YoY to $91.0M; Corporate channel exceeded 9% growth. Company narrowed full-year revenue/EBITDA guidance and raised adjusted EPS guidance. Share buybacks and debt repurchase programs active.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed as the filings read less positively.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Kronos reported Q3 2026 net income of $34.8M vs. prior-year loss of $37.0M. Nine-month net income of $45.2M vs. loss of $28.1M. Driven by higher sales volumes, market share gains, lower raw material costs, and successful price increases despite end-use demand below historical levels.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Biotech
Sarepta Therapeutics, Inc.SRPT
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 earnings show net investment income of $0.46/share exceeding $0.40 dividend, but NAV declined $0.29/share. Non-accrual investments increased to 3.6% of debt from 2.7%, and realized/unrealized losses totaled $0.36/share, signaling credit stress.
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
The gap narrowed — attention is catching up.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
AGO reported Q3 2026 net income of $78M ($1.75/share) with strong new business production of $127M GWP and $128M PVP. Financial Guaranty segment showed growth across all three markets, with global structured finance doubling. Adjusted book value per share reached historic highs at $192.60.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
BJ's Restaurants reported Q3 2026 results with 8.1% comparable sales growth, 27.9% restaurant-level operating profit increase, and raised full-year 2026 guidance across comparable sales, operating profit, and EBITDA metrics.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Biotech
Halozyme Therapeutics, Inc.HALO
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
PSEC reported Q3 2026 results with NII of $76.4M ($0.15/share), down from $77.7M prior quarter. Net loss of $53.4M reflects portfolio valuation declines. Company declared $0.035/share monthly distributions and announced $200M share repurchase authorization.
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Eplus IncPLUS
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
Cooper-Standard Holdings Inc.CPS
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
10-QFiled 5 Nov 2026Industrials
Cooper-Standard Holdings Inc.CPS
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
James Hardie Industries plcJHX
Quarterly report (10-Q), period ending 30 Sep 2026
AIR measured this for the first time; no change to report.
More of the market is starting to notice.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026All industries
Fidelity National Financial, Inc.FNF
8-K · Item 2.02 — Results of operations
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
Yelp IncYELP
8-K · Item 2.02 — Results of operations
Q3 2026 revenue declined 1% YoY to $371M; net income fell to $35M (9% margin) from prior year; Adjusted EBITDA decreased 6% YoY to $92M. Full-year guidance lowered. Advertising revenue remains pressured despite growth in other revenue.
The gap narrowed — attention is catching up.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
The filings read more positively.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Biotech
Verastem, Inc.VSTM
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
10-QFiled 5 Nov 2026All industries
Trupanion, Inc.TRUP
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026Industrials
Callaway Golf CoCALY
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Veracyte, Inc.VCYT
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
Six Flags Entertainment Corporation/NEWFUN
8-K · Item 2.02 — Results of operations
Q3 2026 reported revenues down 11% YoY (1.4% same-park growth). Net loss $366M vs. $1.19B prior year (impairment-driven). Adjusted EBITDA down 11.1% reported, up 1.1% same-park. October softened by weather and Six Flags Over Georgia incident; Q4 guidance reduced to $140–150M Adjusted EBITDA vs. $167M prior year.
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 27 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Genpact reported Q3 2026 results with 7.3% YoY revenue growth and Advanced Technology Solutions up 30.3% YoY. Company raised full-year 2026 guidance for gross margin (to ~36.9%, +90 bps) and adjusted diluted EPS growth (to ≥13% YoY).
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
AMERICAN COASTAL INSURANCE CorpACIC
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 5 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $230M with 64% gross margin; positive net income of $1M. Major milestone: received final DEA registrations for medical marijuana dispensaries under Schedule III rescheduling. Strong cash generation ($183M operating cash flow YTD) and operational expansion.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Sezzle Inc.SEZL
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026Semiconductors
Solaredge Technologies, Inc.SEDG
Quarterly report (10-Q), period ending 30 Sep 2026
The gap closed as the filings read less positively.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
10-QFiled 5 Nov 2026Software / SaaS
Healthstream IncHSTM
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
10-QFiled 5 Nov 2026Software / SaaS
Sabre CorpSABR
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
8-KFiled 5 Nov 2026Biotech
Agios Pharmaceuticals, Inc.AGIO
8-K · Item 2.02 — Results of operations
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Eve reported Q3 2026 net loss of $58.1M (vs. $46.9M YoY), driven by higher R&D spending on eVTOL development. Engineering prototype completed 73 flights validating 91% of planned checkpoints. Certification progress includes ANAC Basis of Certification published, FAA validation formalized, and EASA application accepted. Cash position of $356M with total liquidity of $470.4M sufficient through 2028.
No notable change in AIR's read.
10-QFiled 5 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026All industries
Hudson Pacific Properties, Inc.HPP
8-K · Item 2.02 — Results of operations
HPP reported Q3 2026 results with fifth consecutive quarter of office occupancy growth to 85.6%, executed 534k sq ft of leases, reduced debt 14% YoY, and raised full-year Core FFO guidance to $1.15–$1.21/share from $1.12–$1.20.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Carlyle Secured Lending, Inc.CGBD
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Carlyle reported Q3 2026 results with GAAP net loss of $8M but strong Distributable Earnings of $433M ($1.12/share). AUM grew to $479B; pending fee-earning AUM up 48% YTD. Approaching $100B distributions since 2024; declared $0.35 dividend.
No notable change in AIR's read.
10-QFiled 5 Nov 2026Biotech
Prothena Corp Public Ltd CoPRTA
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
Compass, Inc.COMP
8-K · Item 2.02 — Results of operations
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
News CorpNWSA
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Maplebear Inc.CART
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
More of the market is starting to notice.
The shares became dearer on AIR's value read.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The shares became dearer on AIR's value read.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
El Pollo Loco Holdings, Inc.LOCO
8-K · Item 2.02 — Results of operations
Q3 2026 results show revenue growth to $126.3M and positive comp sales of 5.0%, but net income and adjusted EBITDA declined year-over-year. Company guides 2027 expansion of 25-30 new restaurants.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Banks
Pra Group IncPRAA
8-K · Item 2.02 — Results of operations
Q3 2026 results show net income of $15M vs. loss in prior year, portfolio income up 5%, adjusted cash efficiency improved 200+ bps, and Adjusted EBITDA up 9%. Company issued $400M senior notes extending debt maturity.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Itt Inc.ITT
Quarterly report (10-Q), period ending 3 Oct 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed as the filings read less positively.
10-QFiled 5 Nov 2026All industries
Sonida Senior Living, Inc.SNDA
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Semiconductors
SYNAPTICS IncSYNA
8-K · Item 2.02 — Results of operations
Synaptics reported Q1 FY2027 revenue of $294.0M (up 1% YoY) with GAAP loss of $0.45/share but Non-GAAP EPS of $1.26. Key highlights include new xMCU microcontroller launch and expanded AI partnerships. Pending onsemi all-cash acquisition restructured from all-stock deal.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Q3 2026 net sales declined 7.6% YoY to $836M; adjusted EPS fell 29.4% to $0.29. FY2026 outlook reduced to ~$3.5B sales and $1.20–$1.30 adjusted EPS. Operating cash flow halved; free cash flow collapsed to $0M.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
Callaway Golf CoCALY
8-K · Item 2.02 — Results of operations
Callaway Golf reported Q3 2026 results exceeding expectations with net sales and Adjusted EBITDA beating guidance. Gross margins expanded significantly (1,210 bps GAAP, 520 bps non-GAAP YoY). Company raised full-year 2026 net sales and Adjusted EBITDA outlook. Operating cash flow increased 45% YTD.
No notable change in AIR's read.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.